DigitalOcean gains on analyst upgrade, AI product momentum, and approaching earnings

DigitalOcean Holdings (DOCN) is up 6.8% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears tied to a mix of bullish positioning ahead of DigitalOcean’s November 3, 2026 earnings report, continued enthusiasm around its recent AI-agent product rollout, and a recent analyst upgrade. While no single same-day catalyst stands out clearly, investors seem to be leaning into the company’s AI growth narrative after strong prior guidance.

Details:

DigitalOcean said on October 20 that it will report third-quarter 2026 results before the market opens on November 3, putting a near-term catalyst in focus.

In its latest quarterly materials, the company raised its full-year 2026 revenue outlook and highlighted rapid growth in AI customer ARR and million-dollar customer ARR.

Over the past month, DigitalOcean launched Managed Agents, Agent Droplets, and new agent learning and data services, reinforcing its push to become an AI-native cloud platform.

Piper Sandler upgraded the stock to Overweight on October 21, which could still be supporting sentiment after a recent pullback.

Sources:

DigitalOcean Investor Relations, TipRanks, StreetInsider

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$DOCN Insider Trading Activity

$DOCN insiders have traded $DOCN stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales.

Here’s a breakdown of recent trading of $DOCN stock by insiders over the last 6 months:

INDUSTRIES HOLDINGS LLC ACCESS has made 0 purchases and 2 sales selling 3,300,000 shares for an estimated $495,990,000.
MATT STEINFORT (Chief Financial Officer) has made 0 purchases and 3 sales selling 45,000 shares for an estimated $6,570,500.
WARREN JENSON sold 20,000 shares for an estimated $2,952,400
PADMANABHAN T SRINIVASAN (Chief Executive Officer) has made 0 purchases and 3 sales selling 22,788 shares for an estimated $2,933,043.
CHERIE BARRETT (SVP, Chief Accounting Officer) has made 0 purchases and 2 sales selling 8,441 shares for an estimated $1,011,174.
HILARY SCHNEIDER sold 4,338 shares for an estimated $678,376
WARREN J ADELMAN sold 4,200 shares for an estimated $520,854

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

EARLY ACCESS

Receive DOCN Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$DOCN Hedge Fund Activity

We have seen 306 institutional investors add shares of $DOCN stock to their portfolio, and 259 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

JPMORGAN CHASE & CO added 13,850,206 shares (+inf%) to their portfolio in Q2 2026, for an estimated $2,174,897,848
BLACKROCK, INC. removed 3,185,629 shares (-26.6%) from their portfolio in Q2 2026, for an estimated $500,239,321
TWO SIGMA INVESTMENTS, LP added 1,697,290 shares (+896.4%) to their portfolio in Q2 2026, for an estimated $266,525,448
WELLINGTON MANAGEMENT GROUP LLP removed 1,383,571 shares (-46.8%) from their portfolio in Q2 2026, for an estimated $217,262,154
ALLIANCEBERNSTEIN L.P. removed 1,351,038 shares (-59.2%) from their portfolio in Q2 2026, for an estimated $212,153,497
JACOBS LEVY EQUITY MANAGEMENT, INC removed 884,663 shares (-96.8%) from their portfolio in Q2 2026, for an estimated $138,918,630
UBS GROUP AG removed 864,592 shares (-58.8%) from their portfolio in Q2 2026, for an estimated $135,766,881

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$DOCN Price Targets

Multiple analysts have issued price targets for $DOCN recently. We have seen 9 analysts offer price targets for $DOCN in the last 6 months, with a median target of $184.0.

Here are some recent targets:

Raimo Lenschow from Barclays set a target price of $184.0 on 07/08/2026
Mark Zhang from Citigroup set a target price of $185.0 on 07/08/2026
Radi Sultan from UBS set a target price of $155.0 on 07/08/2026
Kingsley Crane from Canaccord Genuity set a target price of $200.0 on 06/11/2026
Jackson Ader from Keybanc set a target price of $200.0 on 06/03/2026
Gabriela Borges from Goldman Sachs set a target price of $179.0 on 05/07/2026
James Fish from Piper Sandler set a target price of $155.0 on 05/06/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.